NO970312L - Karbonmonoksidavhengige guanylylcyklase modifiseringsmidler - Google Patents
Karbonmonoksidavhengige guanylylcyklase modifiseringsmidlerInfo
- Publication number
- NO970312L NO970312L NO970312A NO970312A NO970312L NO 970312 L NO970312 L NO 970312L NO 970312 A NO970312 A NO 970312A NO 970312 A NO970312 A NO 970312A NO 970312 L NO970312 L NO 970312L
- Authority
- NO
- Norway
- Prior art keywords
- naturally occurring
- cellular
- carbon monoxide
- guanylyl cyclase
- variety
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/280,719 US5447939A (en) | 1994-07-25 | 1994-07-25 | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US08/488,976 US5801184A (en) | 1994-07-25 | 1995-06-08 | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US49292995A | 1995-07-20 | 1995-07-20 | |
PCT/US1995/010008 WO1996003125A1 (en) | 1994-07-25 | 1995-07-25 | Carbon monoxide dependent guanylyl cyclase modifiers |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970312D0 NO970312D0 (no) | 1997-01-24 |
NO970312L true NO970312L (no) | 1997-01-27 |
Family
ID=27403169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970312A NO970312L (no) | 1994-07-25 | 1997-01-24 | Karbonmonoksidavhengige guanylylcyklase modifiseringsmidler |
Country Status (13)
Country | Link |
---|---|
US (3) | US6350752B1 (cs) |
EP (1) | EP0772440A4 (cs) |
JP (1) | JPH10504814A (cs) |
AU (1) | AU709454B2 (cs) |
BR (1) | BR9508339A (cs) |
CA (1) | CA2195302A1 (cs) |
CZ (1) | CZ380296A3 (cs) |
FI (1) | FI970302A (cs) |
HU (1) | HUT76294A (cs) |
NO (1) | NO970312L (cs) |
NZ (1) | NZ291592A (cs) |
PL (1) | PL318293A1 (cs) |
WO (1) | WO1996003125A1 (cs) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6338963B1 (en) * | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
DK1790344T3 (da) * | 2000-07-07 | 2011-05-02 | Spectrum Pharmaceuticals Inc | Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande |
FR2814077A1 (fr) * | 2000-09-20 | 2002-03-22 | Inst Nat Sante Rech Med | Utilisation de modulateurs de recepteurs a l'adenosine pour reguler la fonction des netrines et/ou de leurs recepteurs |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US7011854B2 (en) * | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
CN100436468C (zh) * | 2005-06-24 | 2008-11-26 | 中国医学科学院基础医学研究所 | 一类嘌呤核苷酸化合物、其药物组合物及其制药用途 |
WO2007073226A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda | Method for treating a mammal by administration of a compound having the ability to release co |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
US20120058099A1 (en) * | 2009-03-04 | 2012-03-08 | Children's Medical Center Corporation | Use of hypoxanthine for promotion of neuronal outgrowth |
WO2012145520A2 (en) | 2011-04-19 | 2012-10-26 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
WO2013013179A1 (en) | 2011-07-21 | 2013-01-24 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3321369A (en) | 1965-05-26 | 1967-05-23 | Abbott Lab | Method of enhancing learning rate and retention level in warm blooded animals |
US3438968A (en) | 1966-06-23 | 1969-04-15 | Int Chem & Nuclear Corp | Substituted ammonium basic addition salts of ribonucleic acid |
DE2554453A1 (de) * | 1974-12-18 | 1976-06-24 | Experimentales Et Cliniques De | Medikament zur glykaemieregulierung |
US4221909A (en) | 1978-09-15 | 1980-09-09 | Sloan-Kettering Institute For Cancer Research | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
US4221910A (en) | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
US4221794A (en) | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
US4728605A (en) | 1984-07-31 | 1988-03-01 | Fudenberg Herman H | Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same |
US4952693A (en) | 1984-10-12 | 1990-08-28 | Warner-Lambert Company | Oxazolo-pyrimidine derivatives |
US5151438A (en) * | 1989-05-23 | 1992-09-29 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5256677A (en) * | 1989-05-23 | 1993-10-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5091432A (en) * | 1990-03-28 | 1992-02-25 | Glasky Alvin J | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
FR2692784B1 (fr) * | 1992-06-24 | 1995-06-30 | Pf Medicament | Utilisation de la guanosine, de ses precurseurs et ses derives pour la fabrication de medicaments destines a traiter les deficits fonctionnels cerebraux. |
US5447939A (en) | 1994-07-25 | 1995-09-05 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
DK1790344T3 (da) * | 2000-07-07 | 2011-05-02 | Spectrum Pharmaceuticals Inc | Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande |
-
1995
- 1995-07-25 WO PCT/US1995/010008 patent/WO1996003125A1/en not_active Application Discontinuation
- 1995-07-25 HU HU9603591A patent/HUT76294A/hu unknown
- 1995-07-25 PL PL95318293A patent/PL318293A1/xx unknown
- 1995-07-25 CA CA002195302A patent/CA2195302A1/en not_active Abandoned
- 1995-07-25 CZ CZ963802A patent/CZ380296A3/cs unknown
- 1995-07-25 AU AU32775/95A patent/AU709454B2/en not_active Ceased
- 1995-07-25 JP JP8506010A patent/JPH10504814A/ja active Pending
- 1995-07-25 EP EP95929408A patent/EP0772440A4/en not_active Withdrawn
- 1995-07-25 NZ NZ291592A patent/NZ291592A/en unknown
- 1995-07-25 BR BR9508339A patent/BR9508339A/pt not_active Application Discontinuation
-
1997
- 1997-01-24 NO NO970312A patent/NO970312L/no not_active Application Discontinuation
- 1997-01-24 FI FI970302A patent/FI970302A/fi unknown
- 1997-06-19 US US08/878,656 patent/US6350752B1/en not_active Expired - Fee Related
-
2002
- 2002-02-04 US US10/067,662 patent/US20020165242A1/en not_active Abandoned
-
2005
- 2005-09-29 US US11/240,587 patent/US20060063788A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996003125A1 (en) | 1996-02-08 |
US6350752B1 (en) | 2002-02-26 |
AU3277595A (en) | 1996-02-22 |
HUT76294A (en) | 1997-07-28 |
BR9508339A (pt) | 1997-09-30 |
FI970302A0 (fi) | 1997-01-24 |
FI970302A (fi) | 1997-01-24 |
NZ291592A (en) | 2001-03-30 |
EP0772440A4 (en) | 1999-05-19 |
US20020165242A1 (en) | 2002-11-07 |
JPH10504814A (ja) | 1998-05-12 |
US20060063788A1 (en) | 2006-03-23 |
HU9603591D0 (en) | 1997-02-28 |
NO970312D0 (no) | 1997-01-24 |
PL318293A1 (en) | 1997-06-09 |
CZ380296A3 (cs) | 1998-01-14 |
EP0772440A1 (en) | 1997-05-14 |
AU709454B2 (en) | 1999-08-26 |
CA2195302A1 (en) | 1996-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970312L (no) | Karbonmonoksidavhengige guanylylcyklase modifiseringsmidler | |
IL121790A0 (en) | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (GDNF) protein product | |
AU3368497A (en) | Human dnase i hyperactive variants | |
PL322015A1 (en) | Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them | |
AU2155795A (en) | Alphavirus cdna vectors | |
WO2003104270A3 (en) | GENES OF DUDULINE 2, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASES | |
DE69737740D1 (de) | GDP-Dissoziation stimulierendes Protein, gehirnspezifisches Nucleosomfügungsprotein, Skelettmuskel-spezifisches Ubiquitin-Conjugationsenzym, Zellproliferationsprotein, Phosphatidylinositolkinase, Nel verwandte Proteine | |
IL190793A0 (en) | A fusion polypeptide comprising a collagen binding domain and an angiogenesis modulating domain | |
CA2223433A1 (en) | Ob protein compositions and methods | |
MY134810A (en) | Targeted gene expression of thrombopoietein, dnase i and b-interferon | |
BG102733A (en) | New substituted cyclic amino acids as pharmaceutical forms | |
PT917571E (pt) | Gene relacionado com agouti | |
ATE280833T1 (de) | Kationische lipide/dns komplexe zum zielen von genen | |
ATE374251T1 (de) | Zusammensetzungen zur gentherapie von diabetes | |
NZ314839A (en) | 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues | |
WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
NO20021829L (no) | Anvendelse av karbonmonoksyd-avhengige guanylylcyklase- modifisatorer for å stimulere neuritogenese | |
WO1998020029A3 (en) | Hnf3-delta compositions | |
CN100378087C (zh) | 抗坏血酸化合物,合成方法及其应用 | |
ATE246935T1 (de) | Zns neuroregenerative zusammensetzungen und deren verwendungen | |
AU8811298A (en) | Novel peptides and polypeptides useful for regenerating the nervous system | |
MX9705198A (es) | Metodos y formulaciones a base de colagena para el tratamiento de enfermedades mediadas por el sistema inmune. | |
DE69529750D1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
MX9700664A (es) | Modificadores de guanililciclasa, dependientes del monoxido de carbono. | |
WO2001044443A3 (en) | Cytochrome p450rai-2 and related proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |